Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb 14;14(2):484.
doi: 10.3390/genes14020484.

Coexistence of Genetic Diseases Is a New Clinical Challenge: Three Unrelated Cases of Dual Diagnosis

Affiliations
Case Reports

Coexistence of Genetic Diseases Is a New Clinical Challenge: Three Unrelated Cases of Dual Diagnosis

Anna Paola Capra et al. Genes (Basel). .

Abstract

Technological advancements in molecular genetics and cytogenetics have led to the diagnostic definition of complex or atypical clinical pictures. In this paper, a genetic analysis identifies multimorbidities, one due to either a copy number variant or a chromosome aneuploidy, and a second due to biallelic sequence variants in a gene associated with an autosomal recessive disorder. We diagnosed the simultaneous presence of these conditions, which co-occurred by chance, in three unrelated patients: a 10q11.22q11.23 microduplication and a homozygous variant, c.3470A>G (p.Tyr1157Cys), in the WDR19 gene associated with autosomal recessive ciliopathy; down syndrome and two variants, c.850G>A; p.(Gly284Arg) and c.5374G>T; p.(Glu1792*), in the LAMA2 gene associated with merosin-deficient congenital muscular dystrophy type 1A (MDC1A); and a de novo 16p11.2 microdeletion syndrome and homozygous variant, c.2828G>A (p.Arg943Gln), in the ABCA4 gene associated with Stargardt disease 1 (STGD1). The possibility of being affected by two relatively common or rare inherited genetic conditions would be suspected when signs and symptoms are incoherent with the primary diagnosis. All this could have important implications for improving genetic counseling, determining the correct prognosis, and, consequently, organizing the best long-term follow-up.

Keywords: clinical competence; diagnosis; genetic diseases; phenotype; rare diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Brown H.L., Sherburn I.A., Gaff C., Taylor N., Best S. Structured approaches to implementation of clinical genomics: A scoping review. Genet. Med. 2022;24:1415–1424. doi: 10.1016/j.gim.2022.03.017. - DOI - PubMed
    1. Ardizzone A., Capra A.P., Campolo M., Filippone A., Esposito E., Briuglia S. Neurofibromatosis: New Clinical Challenges in the Era of COVID-19. Biomedicines. 2022;10:940. doi: 10.3390/biomedicines10050940. - DOI - PMC - PubMed
    1. Merker V.L., Slobogean B., Jordan J.T., Langmead S., Meterko M., Charns M.P., Elwy A.R., Blakeley J.O., Plotkin S.R. Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis. Am. J. Med. Genet. A. 2022;188:2672–2683. doi: 10.1002/ajmg.a.62860. - DOI - PMC - PubMed
    1. Valderas J.M., Starfield B., Sibbald B., Salisbury C., Roland M. Defining comorbidity: Implications for understanding health and health services. Ann. Fam. Med. 2009;7:357–363. doi: 10.1370/afm.983. - DOI - PMC - PubMed
    1. Gavassini B.F., Carboni N., Nielsen J.E., Danielsen E.R., Thomsen C., Svenstrup K., Bello L., Maioli M.A., Marrosu G., Ticca A.F., et al. Clinical and molecular characterization of limb-girdle muscular dystrophy due to LAMA2 mutations. Muscle Nerve. 2011;44:703–709. doi: 10.1002/mus.22132. - DOI - PubMed

Publication types

Substances

Supplementary concepts